- This event has passed.
Optimizing Treatment Outcomes for HR+ and HER2-ve Metastatic Breast Cancer
Dr Amina Kidee
Amina Kidee is a Medical Oncologist at the Aga Khan University Hospital, Mombasa.
Her interests are in breast cancer, GI malignancy, and translational research.
Prof Olivia Pagani
Olivia Pagani was responsible, at the Institute of Oncology of Southern Switzerland (IOSI), for breast cancer medical treatment and clinical research from 2005 to 2019 and of the Clinic for cancer predisposition and high-risk individuals from 2002 to 2019. From 2013 to 2018 she was director of the IOSI Eusoma and Swiss certified Breast Unit and from 2005 to 2008 co-president of the SAKK (Swiss Group for Cancer Research) breast cancer project group.
She is the current coordinator of the breast cancer programme of the European School of Oncology and breast cancer consultant at Hopital Riviera-Chablais, Rennaz, Vaud.
In April 2017 she was nominated Full Professor at the Medical School University of Geneva and in 2019 Full Professor at the Medical School University of Lugano.
Her main research interests in the last years have been breast cancer in young women and advanced breast cancer.
She is panel member of the ESO-ESMO Advanced Breast Cancer (ABC) and chair of the ESO-ESMO Breast Cancer in Young Women Consensus Conferences (BCY). She has been panel member of the San Gallen International Consensus Conference for Early Breast cancer in 2017 and 2019.
Moderator: Dr Siwillis Mithe
Siwillis Mithe is a clinical radiation oncologist at the Nakuru County Teaching and Referral Hospital with particular interest in breast, pediatric, head and neck and neuro-oncology. She has been key in instituting multidisciplinary meetings within the hospital, problem-oriented research in the department and streamlining patient care within oncology clinics.
She holds a Masters of Medicine in Clinical Oncology and is extensively trained in radiation therapy and chemotherapy for a variety of cancers.
Dr Siwillis has interest in research having attended and presented papers at both local and international conferences and also has a number of publications to her name. She has played a key role in the roll out of National Cancer Screening and Treatment guidelines and has been very instrumental in raising cancer awareness across the country. She is an advocate of quality and affordable cancer care for all patients